The factor structure of the SF-36 in adults with progressive neuromuscular disorders.
暂无分享,去创建一个
[1] C. Falsini,et al. Quality of life in hereditary neuromuscular diseases , 2004, Acta neurologica Scandinavica.
[2] W. Hop,et al. The natural course of non–classic Pompe’s disease; a review of 225 published cases , 2005, Journal of Neurology.
[3] W. Poewe,et al. Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[4] Julie Jomeen,et al. The factor structure of the SF-36 in early pregnancy. , 2005, Journal of psychosomatic research.
[5] W. Mayr,et al. Improvement of Thigh Muscles by Neuromuscular Electrical Stimulation in Patients with Refractory Heart Failure: A Single-Blind, Randomized, Controlled Trial , 2001, American journal of physical medicine & rehabilitation.
[6] K. Kunze,et al. Disability and quality of life in Charcot-Marie-Tooth disease type 1 , 2001, Journal of neurology, neurosurgery, and psychiatry.
[7] P. Bentler,et al. Significance Tests and Goodness of Fit in the Analysis of Covariance Structures , 1980 .
[8] R. Fitzpatrick,et al. Health-Related Quality-of-Life Measurement in Patients with Parkinson’s Disease , 1999, PharmacoEconomics.
[9] M Sullivan,et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. , 1998, Journal of clinical epidemiology.
[10] M. Haber,et al. Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.
[11] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[12] G. Der,et al. A confirmatory factor analysis of the Hospital Anxiety and Depression scale: comparing empirically and theoretically derived structures. , 2000, The British journal of clinical psychology.
[13] Jay J. Han,et al. The Importance of Assessing Quality of Life in Patients with Neuromuscular Disorders , 2007, The American journal of hospice & palliative care.
[14] W. Hooten,et al. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. , 2007, Pain medicine.
[15] Zachary Simmons,et al. Management Strategies for Patients With Amyotrophic Lateral Sclerosis From Diagnosis Through Death , 2005, The neurologist.
[16] A. Lang,et al. Natural History of Oppenheim's Dystonia (DYT1) in Israel , 2003, Journal of child neurology.
[17] M. Rose,et al. Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL) , 2007, Neurology.
[18] Jes Rahbek,et al. Adult life with Duchenne muscular dystrophy: Observations among an emerging and unforeseen patient population , 2005, Pediatric rehabilitation.
[19] J. van Gijn,et al. Quality of life in patients with axonal polyneuropathy , 2000, Journal of Neurology.
[20] R. P. McDonald,et al. Goodness-of-fit indexes in confirmatory factor analysis : The effect of sample size , 1988 .
[21] G. Parry,et al. A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile , 1997, Journal of the Neurological Sciences.
[22] I. Laffont,et al. Health related quality of life in people with hereditary neuromuscular diseases: An investigation of test–retest agreement with comparison between two generic questionnaires, the Nottingham health profile and the short form-36 items , 2006, Neuromuscular Disorders.
[23] P. Bentler,et al. Comparative fit indexes in structural models. , 1990, Psychological bulletin.
[24] M. Schulzer,et al. The psychometric properties of the Parkinson's Impact Scale (PIMS) as a measure of quality of life in Parkinson's disease. , 2003, Parkinsonism & related disorders.
[25] B. Mcfarland,et al. Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide. , 1998, The New England journal of medicine.
[26] R. Abresch,et al. Chronic pain in persons with neuromuscular disease. , 2005, Archives of physical medicine and rehabilitation.
[27] C. Réveillère,et al. Propriétés psychométriques d'un nouvel instrument d'évaluation de la qualité de vie, le WHOQOL-26, à partir d'une population de malades neuro-musculaires , 2000 .
[28] Peter Hagell,et al. Health status measurement in Parkinson's disease: Validity of the PDQ‐39 and Nottingham Health Profile , 2003, Movement disorders : official journal of the Movement Disorder Society.
[29] H. Bozdogan. Model selection and Akaike's Information Criterion (AIC): The general theory and its analytical extensions , 1987 .
[30] B. Grahn,et al. Quality of life and pain in Parkinson's disease: a controlled cross-sectional study. , 2004, Parkinsonism & related disorders.